Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT04359264
  4. Details
NCT04359264 Clinical Trial

Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial

COVID-19 Clinical Trial

— DISTANSE COVID  

Official title:
Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial (DISTANSE COVID-19 RCT)

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT04359264
Other study ID # 20-081
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 20, 2020
Est. completion date December 30, 2020

Study information
Verified date July 2020
Source St. Michael's Hospital, Toronto
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a clinical trial of a cash transfer on symptoms consistent with COVID-19 and adherence to physical distancing guidance.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 392
Est. completion date December 30, 2020
Est. primary completion date May 29, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- trouble "making ends meet at the end of the month" due to COVID-19 related disruptions

Exclusion Criteria:

- confirmed positive for COVID-19 based on laboratory testing

- current symptoms consistent with COVID-19

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Cash transfer
Cash transfer of $1000

Locations
Country Name City State
Canada Municipality of Assiginack Family Health Team Assiginack Ontario
Canada St Michael's Hospital Academic Family Health Team Toronto Ontario

Sponsors (1)
Lead Sponsor Collaborator
St. Michael's Hospital, Toronto

Country where clinical trial is conducted

Canada, 

Outcome
Type Measure Description Time frame Safety issue
Other Health care utilization 14 days
Other Food security Three-items (worry about food running out, food did not last, balanced meals) 14 days
Other Cost-related medicine non-adherence Single item: "During the last two weeks, did you or any member of your household not take a medication, skip some doses, split pills or do anything else to make a medication last longer due to the cost?" 14 days
Primary Symptoms consisent with COVID-19 32-item Influenza Patient-reported Outcome (FLU-PRO) symptom score. Higher score is worse. 14 days
Secondary Number of close contacts Sum of contacts on days 5, 10 and 14
Secondary Number of participants with positive test for COVID-19 14 days
Secondary Self-reported health based on the single question: "In general, would you say your health is.." 14 days
Secondary Ability to make ends meet based on the single question: "At the end of the month, are you able to make ends meet?" 14 days
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure